General Information
DRAVP ID DRAVPe00078
Peptide Name Vpr-1
Sequence LQQLLF
Sequence Length 6
UniProt ID No entry found
Source Synthetic construct(derived from HIV-1 gene products(Vpr))
Activity Information
Target Organism HIV
Assay Luciferase assay
Activity
Hemolytic Activity No hemolysis information or data found in the reference(s) presented in this entry
Cytotoxicity
Binding Target Integrase
Mechanism IN is an essential enzyme for the stable infection of host cells because it catalyzes the insertion of viral DNA inside the pre-integration complex (PIC) into the genome of host cells in two successive reactions, designated as strand transfer and 3′-end-processing. The peptide could inhibit the activity of integrase and thus inhibit virus replication.
Structure Information
PDB ID None
Predicted Structure Download DRAVPe00078
Linear/Cyclic Linear
N-terminal Modification Acetylation
C-terminal Modification Amidation
Other Modification None
Stereochemistry L
Physicochemical Information
Formula C37H60N8O9
Absent amino acids ACDEGHIKMNPRSTVWY
Common amino acids L
Mass 760.93
Pl 5.52
Basic residues 0
Acidic residues 0
Hydrophobic residues 4
Net charge 0
Boman Index 666
Hydrophobicity 120
Aliphatic Index 195
Half Life
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 0
Literature Information
Literature 1
Title Peptide HIV-1 integrase inhibitors from HIV-1 gene products.
Pubmed ID 20586421
Reference J Med Chem. 2010 Jul 22;53(14):5356-60.
Author Suzuki S, Urano E, Hashimoto C, Tsutsumi H, Nakahara T, Tanaka T, Nakanishi Y, Maddali K, Han Y, Hamatake M, Miyauchi K, Pommier Y, Beutler JA, Sugiura W, Fuji H, Hoshino T, Itotani K, Nomura W, Narumi T, Yamamoto N, Komano JA, Tamamura H.